Mediastinal Hepatoid Adenocarcinoma Treated With Arterial Interventional Therapy: A Case Report and Review of Literature

Hepatoid adenocarcinoma (HAC) is an extremely rare extrahepatic carcinoma, which is pathologically featured by hepatocellular carcinoma (HCC) and marked by producing alpha-fetoprotein (AFP). HAC of mediastinum is extremely rare. For inoperable patients, the curative treatment options have not been e...

Full description

Bibliographic Details
Main Authors: Guiyuan Zhang, Chunyong Wen, Bin Chen, Haitao Dai, Run Lin, Yonghui Huang, Xianhong Xiang
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-04-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.785888/full
_version_ 1818271786990567424
author Guiyuan Zhang
Chunyong Wen
Bin Chen
Haitao Dai
Run Lin
Yonghui Huang
Xianhong Xiang
author_facet Guiyuan Zhang
Chunyong Wen
Bin Chen
Haitao Dai
Run Lin
Yonghui Huang
Xianhong Xiang
author_sort Guiyuan Zhang
collection DOAJ
description Hepatoid adenocarcinoma (HAC) is an extremely rare extrahepatic carcinoma, which is pathologically featured by hepatocellular carcinoma (HCC) and marked by producing alpha-fetoprotein (AFP). HAC of mediastinum is extremely rare. For inoperable patients, the curative treatment options have not been established, and the outcome of HAC is usually poor. Here, we present a case of mediastinal HAC with normal serum AFP level who achieved well-controlled and good response after local–regional interventional approach combined with systemic PD-1 inhibitor. A 53-year-old male who complained of chest pain was admitted to our hospital in February 2021. A chest CT scan revealed several tumors in his mediastinum. The laboratory data showed normal serum AFP level. HAC was diagnosed through pathological assessment of biopsy. Surgery was not available due to the infiltration of sternum. Local regional FOLFOX chemotherapy was given by transarterial infusion, followed by transcatheter arterial chemoembolization, and thereafter combined with systemic anti-PD-1 treatment. The patient achieved favorable disease control and apparent symptom relief. So transarterial interventional therapy combined immunotherapy may be a possible and promising treatment for mediastinal HAC.
first_indexed 2024-12-12T21:31:43Z
format Article
id doaj.art-ad9ed60aa5624094b815bf2227ede362
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-12-12T21:31:43Z
publishDate 2022-04-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-ad9ed60aa5624094b815bf2227ede3622022-12-22T00:11:19ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2022-04-011210.3389/fonc.2022.785888785888Mediastinal Hepatoid Adenocarcinoma Treated With Arterial Interventional Therapy: A Case Report and Review of LiteratureGuiyuan ZhangChunyong WenBin ChenHaitao DaiRun LinYonghui HuangXianhong XiangHepatoid adenocarcinoma (HAC) is an extremely rare extrahepatic carcinoma, which is pathologically featured by hepatocellular carcinoma (HCC) and marked by producing alpha-fetoprotein (AFP). HAC of mediastinum is extremely rare. For inoperable patients, the curative treatment options have not been established, and the outcome of HAC is usually poor. Here, we present a case of mediastinal HAC with normal serum AFP level who achieved well-controlled and good response after local–regional interventional approach combined with systemic PD-1 inhibitor. A 53-year-old male who complained of chest pain was admitted to our hospital in February 2021. A chest CT scan revealed several tumors in his mediastinum. The laboratory data showed normal serum AFP level. HAC was diagnosed through pathological assessment of biopsy. Surgery was not available due to the infiltration of sternum. Local regional FOLFOX chemotherapy was given by transarterial infusion, followed by transcatheter arterial chemoembolization, and thereafter combined with systemic anti-PD-1 treatment. The patient achieved favorable disease control and apparent symptom relief. So transarterial interventional therapy combined immunotherapy may be a possible and promising treatment for mediastinal HAC.https://www.frontiersin.org/articles/10.3389/fonc.2022.785888/fullhepatoid adenocarcinomamediastinalarterial infusioninterventional radiologyprognosis
spellingShingle Guiyuan Zhang
Chunyong Wen
Bin Chen
Haitao Dai
Run Lin
Yonghui Huang
Xianhong Xiang
Mediastinal Hepatoid Adenocarcinoma Treated With Arterial Interventional Therapy: A Case Report and Review of Literature
Frontiers in Oncology
hepatoid adenocarcinoma
mediastinal
arterial infusion
interventional radiology
prognosis
title Mediastinal Hepatoid Adenocarcinoma Treated With Arterial Interventional Therapy: A Case Report and Review of Literature
title_full Mediastinal Hepatoid Adenocarcinoma Treated With Arterial Interventional Therapy: A Case Report and Review of Literature
title_fullStr Mediastinal Hepatoid Adenocarcinoma Treated With Arterial Interventional Therapy: A Case Report and Review of Literature
title_full_unstemmed Mediastinal Hepatoid Adenocarcinoma Treated With Arterial Interventional Therapy: A Case Report and Review of Literature
title_short Mediastinal Hepatoid Adenocarcinoma Treated With Arterial Interventional Therapy: A Case Report and Review of Literature
title_sort mediastinal hepatoid adenocarcinoma treated with arterial interventional therapy a case report and review of literature
topic hepatoid adenocarcinoma
mediastinal
arterial infusion
interventional radiology
prognosis
url https://www.frontiersin.org/articles/10.3389/fonc.2022.785888/full
work_keys_str_mv AT guiyuanzhang mediastinalhepatoidadenocarcinomatreatedwitharterialinterventionaltherapyacasereportandreviewofliterature
AT chunyongwen mediastinalhepatoidadenocarcinomatreatedwitharterialinterventionaltherapyacasereportandreviewofliterature
AT binchen mediastinalhepatoidadenocarcinomatreatedwitharterialinterventionaltherapyacasereportandreviewofliterature
AT haitaodai mediastinalhepatoidadenocarcinomatreatedwitharterialinterventionaltherapyacasereportandreviewofliterature
AT runlin mediastinalhepatoidadenocarcinomatreatedwitharterialinterventionaltherapyacasereportandreviewofliterature
AT yonghuihuang mediastinalhepatoidadenocarcinomatreatedwitharterialinterventionaltherapyacasereportandreviewofliterature
AT xianhongxiang mediastinalhepatoidadenocarcinomatreatedwitharterialinterventionaltherapyacasereportandreviewofliterature